A ngiopoietin (Ang)-1 and Ang2 have recently been identified as ligands of the endothelial cell-specific Tie2 receptor. 1, 2 In vivo analyses by targeted gene inactivation and transgenic overexpression suggest that Ang1 recruits and sustains periendothelial support cells, whereas Ang2 disrupts blood vessel formation in the developing embryo by antagonizing the effects of Ang1 on Tie2. 2, 3 Interestingly, transgenic overexpression 4 or gene transfer 5 of Ang1 increases vascularization in vivo. In vitro experiments have shown that Ang1 has specific effects on endothelial cells; it potently induces chemotactic response, 6 network formation, 7 and survival in apoptosis. 8, 9 Ang1 also causes sprouting of endothelial cells in fibrin gel, although it has no proliferative effect. 10, 11 The sprouting of endothelial cells is an initial step in angiogenesis and neovascularization. 12, 13 Sprouting requires cell migration into the extracellular matrix beneath the basement membrane. 12, 13 Cell migration requires reorganization of the actin cytoskeleton. 14 A member of the non-receptor protein tyrosine kinases, p125 FAK , plays a key role in regulating dynamic changes in actin cytoskeleton organization during migration and adhesion. 15 p125 FAK is activated by tyrosine phosphorylation, which is induced by growth factors. 16 Paxillin is a cytoskeletal protein involved in actin-membrane attachment at sites of cell adhesion and is associated with p125 FAK . 17 Phosphorylation of p125
FAK produces simultaneous phosphorylation of paxillin. 17 Endothelial cells release proteinases to degrade extracellular matrix for their migration during the sprouting process in vivo. 18, 19 One family of such enzymes is the matrix metalloproteinases (MMPs). 20 MMPs are secreted in a proenzyme form and require proteolytic cleavage for activation. 21, 22 MMPs are inhibited by endogenous tissue inhibitors of metalloproteinase (TIMPs), which form 1:1 complexes with MMPs. 21, 22 The balance between the levels of MMPs and TIMPs is a critical factor in regulating the breakdown of connective tissues by migrating cells.
In this report, we investigate the possible mechanisms of Ang1-induced sprouting in endothelial cells. Ang1-induced migration may occur through tyrosine phosphorylation of p125 FAK and paxillin. In addition, Ang1 induced the secretion of plasmin and increased the secretion ratio of MMP-2/ TIMP-2. Therefore, we propose that Ang1-induced sprouting activity in endothelial cells may be accomplished by cytoskeletal changes and secretion of proteinases.
Materials and Methods

Materials and Cell Culture
The Ang1*, Ang2, soluble Tie1 receptor-Fc (rTie1-Fc), and soluble Tie2 receptor-Fc (rTie2-Fc) proteins were obtained from Regeneron Pharmaceuticals, Inc. Ang1* is a recombinant version of Ang1 with modified NH 2 terminus and mutated Cys 245 that is easier to produce and purify. Mutation of Cys 245 in Ang1, which is not shared between Ang1 and Ang2, does not alter its agonistic property. 2 Recombinant human vascular endothelial growth factor 165 (VEGF 165 ) was purchased from R&D systems. Phosphatidylinositol (PI) 3Ј-kinase inhibitors wortmannin and LY294002 were purchased from RBI, Inc. Recombinant human TIMP-1 and TIMP-2 were purchased from Fuji Chemical Industries. Media and sera were obtained from Life Technologies, Inc. Most other biochemical reagents were purchased from Sigma, unless otherwise specified. All cells used in this study were porcine pulmonary artery endothelial cells (PPAECs). PPAECs were prepared from porcine pulmonary arteries by collagenase digestion and maintained as previously described. 11
Sprouting Assay
The sprouting assay in PPAECs was performed as previously described. 11 Briefly, PPAECs were grown to confluence on microcarrier beads (diameter 175 m; Sigma) and placed in a 2.5 mg/mL fibrinogen gel containing 2.0% heat-inactivated FBS and the indicated recombinant protein. Fibrin gels were incubated in DMEM with a daily addition of the same amount of recombinant protein. After 3 days, 2 independent, blinded investigators counted the number of sprouts with the use of an inverted microscope.
Nondirectional and Directional Migration Assays
For the nondirectional migration assay, the microcarrier bead migration method was used. 23 For the directional migration assay, the method using a modified Boyden chamber (Neuroprobe, Inc) was used.
p125 FAK and Paxillin Tyrosine Phosphorylation Assay
PPAECs were incubated in serum-free DMEM for 24 hours. Then, Ang1* was added at the indicated amounts and incubated for the indicated times. The phosphorylation status of immunoprecipitated protein was detected by Western blot analysis using antiphosphotyrosine, anti-p125 FAK , or anti-paxillin antibody as previously described. 11
Measurements of Plasmin and MMPs in Culture Medium
Confluent PPAECs were incubated in serum-free and phenol red-free DMEM for 24 hours. After the cells were washed with fresh medium, control buffer, Ang1*, or VEGF was applied for the indicated times. Plasmin activities were measured in the media by fibrin-zymography and by a colorimetric assay according to the manufacturer's protocol (Chromozym PL, Boehringer Mannheim). The actual amounts of the proforms of the MMPs (proMMPs), TIMP-1, and TIMP-2 were assayed with enzyme immunoassays according to the manufacturer's protocol (Fuji Chemical Industries). The hydrolytic activities of MMP-2 and MMP-9 were measured by gelatin-zymography as previously described. 24 
Statistics
Data are expressed as meanϮSD. Statistical significance was tested using 1-way ANOVA followed by the Student-Newman-Keuls test. Statistical significance was set at PϽ0.05.
An expanded Materials and Methods section is available online at http://www.circresaha.org.
Results
Ang1*, but Not Ang2, Induces Sprouting in PPAECs
The placement of microcarrier beads onto a confluent monolayer of PPAECs for 2 to 3 days produces beads covered by a confluent monolayer of cells with Ϸ25 to 30 cells per bead.
These beads were embedded in 3-dimensional fibrin gels and cultured. Daily addition of Ang1* (50 to 400 ng/mL) increased sprout formation in a dose-dependent manner, whereas Ang2 (50 to 400 ng/mL) did not increase sprout formation ( Figures 1A and 1B) . Koblizek et al 6 obtained similar results with adrenal cortex-derived microvascular endothelial cells, although the magnitude of sprout formation Figure 1 . Effect of Ang1*, Ang2, and VEGF 165 on sprouting activity in PPAECs. Cells grown on microcarrier beads were placed in fibrin gels containing control buffer, Ang1* (200 ng/mL), Ang2 (200 ng/mL), or VEGF 165 (10 ng/mL) and were incubated with daily supplementation with the same amount of recombinant protein. A, Representative phase-contrast photographs of sprouting activity. Note that more, thinner, and longer sprouts are formed in VEGF-treated beads than in Ang1*-treated beads, whereas only a few short sprouts are formed in control and Ang2-treated beads. Magnifications are ϫ200. B, Quantification of the sprouting activities. Number of endothelial sprouts with length exceeding the diameter of the microcarrier beads (175 m) per 50 microcarrier beads was counted after 3 days. Data are meanϮSD from 5 experiments. *PϽ0.05 vs control.
was somewhat lower than ours. 6 As a positive control, VEGF (1 to 10 ng/mL) increased sprout formation in a dosedependent manner ( Figures 1A and 1B) . In general, the relative potency in sprouting formation produced by VEGF was higher than that produced by Ang1*.
Ang1*, but Not Ang2, Induces Nondirectional and Directional Migration for PPAECs Through Tie-2 Receptor Binding
When PPAEC-bearing microcarrier beads were placed onto gelatinized plastic dishes with control buffer for 20 hours, they yielded a basal level of nondirectional migration (Ϸ40 to 45 cells per 10 beads; Figures 2A and 2B ). The number of migrating cells increased with Ang1* stimulation in a dosedependent manner. In contrast, Ang2 (50 to 400 ng/mL) did not produce any increase in nondirectional migration. Consistent with a previous report, 7 Ang1*, but not Ang2, also induced directional (chemotactic) migration in a dosedependent manner ( Figure 2B ). As a positive control, VEGF induced nondirectional and directional migration in a dosedependent manner ( Figure 2B ). A 5-fold molar excess of rTie2-Fc, but not rTie1-Fc, almost completely blocked the nondirectional and directional migratory effects of Ang1* ( Figure 2B ).
Ang1* Induces p125 FAK and Paxillin Phosphorylation
Because Ang1* has a migratory effect in endothelial cells, we examined whether Ang1* could stimulate tyrosine phosphorylation of p125 FAK and paxillin. Ang1* (200 ng/mL) induced p125 FAK and paxillin phosphorylation as early as 5 minutes and produced a maximal effect at 10 minutes (Figures 3A and 3B). These effects declined but continued to be higher than control levels at up to 30 to 60 minutes. The maximum mean increases in p125 FAK and paxillin phosphorylation were 3.6-and 2.6-fold, respectively. Ang1* induced p125 FAK and paxillin phosphorylation at 10 minutes in a dose-dependent manner ( Figures 3A and 3B) . Thus, the Ang1*-induced phosphorylation of p125 FAK and of paxillin occurred in the same time frame, and to a similar extent. In contrast, Ang2 (200 and 400 ng/mL) made no change in either p125 FAK or paxillin phosphorylation at 10 minutes after stimulation (data not shown).
PI 3-Kinase Inhibitors Suppress Ang1*-Induced Tyrosine Phosphorylation of p125
FAK and Migration
To examine the involvement of PI 3Ј-kinase in Ang1*-induced tyrosine phosphorylation of p125 FAK and migration in endothelial cells, we examined the effects of PI 3Ј-kinase inhibitors on Ang1*-induced p125 FAK phosphorylation at the peak time point (10 minutes) and migration. PPAECs were preincubated with wortmannin or the structurally unrelated synthetic PI 3Ј-kinase-specific inhibitor, LY294002. Wortmannin or LY294002 almost completely inhibited the Ang1*-induced p125
FAK tyrosine phosphorylation and nondirectional and directional migration (Figures 4 and 5) .
Ang1* Induces Plasmin and MMP Secretion but Suppresses TIMP-2 Secretion
Because of the ability of Ang1 to induce cells to sprout in fibrin gels, we examined whether Ang1* causes plasmin secretion from PPAECs. Addition of Ang1* (200 ng/mL) or VEGF (10 ng/mL) produced Ϸ3.5-or 4.8-fold increases, respectively, in plasmin secretion for 3 hours compared with addition of control buffer ( Figure 6A ). The plasmin secretion was confirmed by 
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fibrin zymography ( Figures 7A and 7B ). Culture medium from Ang1*-or VEGF-treated cells clearly had increased Ϸ85-kDa fibrinolytic bands compared with the cells treated with buffer alone ( Figure 7A ). This effect was still observed in cell media collected 24 hours after treatment ( Figure 7A ).
Preliminary enzyme immunoassay showed that the culture media from PPAECs and other endothelial cells contained marked amounts of proMMP-2, whereas proMMP-1, proMMP-3, and proMMP-9 levels were low or undetectable (data not shown). Addition of Ang1* (200 ng/mL) or VEGF (10 ng/mL) for 3 hours produced Ϸ2.2-or 3.3-fold increases, respectively, in proMMP-2 secretion, compared with control buffer ( Figure 6B ). Although Ang1* or VEGF produced a significant induction of proMMP-3 and proMMP-9 secretion, their increased amounts were low ( Figure 6B ). Neither Ang1* nor VEGF induced proMMP-1 secretion ( Figure 6B ). The profiles of MMP-2 and MMP-9 in the media were semiquantitatively assayed by gelatin zymography. Consistent with the results obtained from the enzyme immunoassays, gelatin zymography revealed that proMMP-2 secretion (Ϸ68 kDa) was dominant ( Figure 7A) . Ang1* or VEGF produced Ϸ1.6-or 1.8-fold induction, respectively, of proMMP-2 secretion in the media at 3 hours ( Figures 7A and 7B) . At 24 hours after Ang1* or VEGF addition, the similar pattern of proMMP-2 secretion was observed (Figures 7A and 7B ). Higher size (Ϸ74 kDa) of gelatinolytic bands were observed in the media at 3 hours and were increased at 24 hours. Addition of Ang1* or VEGF induced these gelatinolytic activities similarly with patterns that resembled proMMP-2. In addition, increased proMMP-9 (Ϸ92 kDa) and active MMP-2 (Ϸ62 kDa) secretions were detected, although their amounts were low (Figures 7A and 7B) . Addition of Ang1* or VEGF for 3 hours produced Ϸ45% or 60% suppression in the basal secretion of TIMP-2 ( Figure 6C) . However, the basal secretion of TIMP-1 was low, and the level was not changed by treatment with either Ang1* or VEGF.
We examined the effect of PI 3Ј-kinase inhibitors on secretion of plasmin, MMP-2, and TIMP-2 from PPAECs. Preincubation with wortmannin (10 nmol/L) or LY294002 (30 nmol/L) produced Ϸ50% to 60% suppression in Ang1*-and VEGF-induced plasmin secretion and Ϸ60% to 65% suppression in the Ang1*-and VEGF-induced MMP-2 secretion (Figures 6A and 6B) . These results were confirmed by gelatin and fibrin zymography ( Figures 7C and 7D) . Interestingly, addition of wortmannin (10 nmol/L) or LY294002 (30 nmol/L) produced Ϸ34% suppression in the basal secretion of TIMP-2 ( Figure 6C ). Under these conditions, addition of Ang1* and VEGF produced a further 45% to 50% suppression in TIMP-2 secretion. These results suggest that activation of PI 3Ј-kinase may be involved in Ang1*-and VEGF-induced plasmin and MMP-2 secretions, but it may not be involved in suppression of TIMP-2 secretion. Because Ang1* induced the secretion of plasmin, we examined the effect of ␣ 2 -antiplasmin (100 mU, added daily) on sprouting activity of cells grown on microcarrier beads in fibrin gels. Addition of ␣ 2 -antiplasmin produced Ϸ53% suppression of Ang1*-induced sprouting activity ( Figures 8A and 8B) . Given that the secretion ratio of MMPs to TIMPs was increased by Ang1*, we examined the effect of TIMPs on Ang1*-induced sprouting. Although the addition of either TIMP-1 (100 ng/mL) or TIMP-2 (100 ng/mL) did not produce a significant suppression of sprouting, a combination of TIMP-1 and TIMP-2 produced Ϸ36% suppression of Ang1*-induced sprouting activity ( Figures 8A and 8B) . Given that PI 3Ј-kinase inhibitors suppress migratory activity and secretion of plasmin and MMP-2, we examined the effect of PI 3Ј-kinase inhibitors on sprouting. Addition of wortmannin (10 nmol/L) or LY294002 (30 nmol/L) produced Ϸ68% or 61% suppression of Ang1*-induced sprouting activity, respectively ( Figures 8A and 8B ).
Discussion
Endothelial cell sprouting is an initial step in angiogenesis and neovascularization. 12, 13 This process requires cell migration and invasion into the extracellular matrix beneath the basement membrane. During initial angiogenesis and vasculogenesis, a variety of growth factors and cytokines are upregulated and exert their functions through autocrine or paracrine actions. Of these, VEGF and Ang1 may be the key molecules, because their receptors are selectively located in endothelial cells. 25, 26 Recent reports indicate that transgenic overexpression or gene transfer of Ang1 increases vascularization. 4, 5 Thus, Ang1 is a reasonable candidate for therapeutic neovascularization for ischemic hearts or limbs. However, the exact mechanisms governing the increased vascularization with Ang1 overexpression are not yet known. Here, our findings explain how Ang1 induces sprouting in endothelial cells for increasing vascularization.
A member of the non-receptor protein-tyrosine kinases, p125 FAK , plays a key role in regulating dynamic changes in actin cytoskeleton organization during migration. 15 Our results indicate that Ang1 induces tyrosine phosphorylation of p125 FAK and paxillin. These phosphorylation events take place rapidly, in a time-and concentration-dependent manner in endothelial cells. Thus, the migratory effect of Ang1 in endothelial cells may be mediated through actin cytoskeleton reorganization by tyrosinephosphorylated p125 FAK and paxillin. We next investigated how Ang1 phosphorylated p125 FAK . Recent studies indicated that Tie2 activates PI 3Ј-kinase through an association with the p85 regulatory unit. 27, 28 Our results indicate that the PI 3Ј-kinase inhibitors completely inhibit Ang1-stimulated tyrosine phosphorylation of p125 FAK in endothelial cells and migration. This result suggests that PI 3Ј-kinase lies upstream in the signal transduction pathway linking Tie2 to the tyrosine phosphorylation of p125 FAK and migration. Therefore, we conclude that PI 3Ј-kinase activation is an essential intracellular element in Ang1-induced cell migration through tyrosine phosphorylation of p125 FAK .
To produce sprouting in response to Ang1 or VEGF stimulation in an in vitro fibrin gel, endothelial cells must secrete fibrinolytic enzymes. To date, the ability of endothelial cells to mediate fibrinolytic activity has been largely attributed to the powerful fibrinolysin, plasmin. 29 As we expected, Ang1 and VEGF induced plasmin secretion. However, a recent study identified MMP-dependent fibrinolytic pathways in the endothelial cells during neovascularization in fibrin gels. 30 However, our PPAECs secrete mainly MMP-2, which exhibits a lack of fibrinolytic activity. 30 Indeed, our fibrin zymography did not produce fibrinolytic bands where MMP-2 was active, whereas it produced strong fibrinolytic bands where plasmin was active. Our gelatin-zymographic assay reveals that Ang1, like VEGF, is a stimulant for secretion of proMMP-2. Although plenty of proMMP-2 is secreted and accumulated in the medium by Ang1 or VEGF stimulation, the conversion from proMMP-2 to active MMP-2 is not proportional. Cell membrane-associated processing with membrane type 1-MMP and TIMP-2 may be required for conversion to active MMP-2. 31 Some larger (Ϸ74 kDa) gelatinolytic bands of unknown nature are observed in the culture medium of PPAECs. They could be proMMP-2 bound with an unknown protein or unknown gelatinase. The balanced ratio between the levels of MMPs and TIMPs is a critical factor in regulating the breakdown of matrix proteins by MMPs. 21, 22 Our results indicate that TIMP-2 secretion is greater than TIMP-1 secretion in PPAECs. Ang1, like VEGF, 32 decreases TIMP-2, but not TIMP-1, secretion. Therefore, the increased ratio between MMPs and TIMPs by Ang1 is favorable for the degradation of matrix proteins. Notably, our results indicate that Figure 8 . Effect of ␣ 2 -antiplasmin, TIMPs, or PI 3Ј-kinase inhibitors on Ang1*-induced sprouting activity in PPAECs. Cells grown on microcarrier beads were placed in fibrin gels containing control buffer (C), ␣ 2 -antiplasmin (AP, 100 mU), TIMP-1 (100 ng/mL) (T1), TIMP-2 (100 ng/mL) (T2), a combination of TIMP-1 (100 ng/mL) and TIMP-2 (100 ng/mL) (T1/2), wortmannin (W, 10 nmol/L), or LY294002 (L, 30 nmol/L) in the absence or presence of Ang1* (200 ng/mL). Beads were incubated with daily supplementation with the same amount of recombinant proteins. A, Representative phase-contrast photographs of sprouting activity. Note that fewer, shorter sprouts are formed in the presence of ␣ 2 -antiplasmin, TIMP-1 plus TIMP-2 (TIMP1/2), or wortmannin than in control. Magnifications are ϫ200. B, Quantification of the sprouting activities. Number of endothelial sprouts with length exceeding the diameter of the microcarrier bead (175 m) was determined for every 50 microcarrier beads counted after 3 days. Data are meanϮSD from 5 experiments. *PϽ0.05 vs control buffer only; #PϽ0.05 vs Ang1* only; †PϽ0.05 vs T1/2 and Ang1*; ϩPϽ0.05 vs AP and Ang1*.
activation of PI 3Ј-kinase could be involved in Ang1*-and VEGF-induced plasmin and MMP-2 secretions but not in TIMP-2 secretion. The mechanisms by which PI 3Ј-kinase is involved in Ang1*-and VEGF-induced plasmin and MMP-2 secretions will be examined in future studies. Given that our sprouting activities were measured in fibrin gels, Ang1-induced plasmin secretion, rather than Ang1-induced MMP-2 secretion, could be a major determinant for sprouting. Consistent with this idea, addition of ␣ 2 -antiplasmin produced a more pronounced suppressive effect than combination of TIMP-1 and TIMP-2 on Ang1-induced sprouting activity. However, the suppressive effect of the combination of TIMP-1 and TIMP-2 was unexpected. Previous studies indicate that TIMPs have several other functions, including inhibition of basic fibroblast growth factor-induced endothelial cell proliferation and endothelial tube formation. 22 Thus, the suppressive effects of TIMPs on Ang1-induced sprouting activity in endothelial cells will be examined in future studies. Given that PI 3Ј-kinase inhibitors suppressed Ang1*-induced migration and secretion of plasmin and MMP-2 in endothelial cells, PI 3Ј-kinase activation could be major intracellular mediator for sprouting. Consistent with this idea, addition of PI 3Ј-kinase inhibitors produced a marked and more pronounced suppressive effect than ␣ 2 -antiplasmin on Ang1-induced sprouting activity.
In summary, the present results explain how Ang1 induces sprouting in endothelial cells. Ang1 induces endothelial cell migration mediated through Tie2 receptor binding and PI 3Ј-kinase activation. The Ang1-induced migratory effect might be mediated through tyrosine phosphorylation of p125 FAK in a manner that requires PI 3Ј-kinase activity. Increased plasmin and MMP-2 secretion from endothelial cells by Ang1 is also an important determinant for inducing sprouting. These secretions are inhibited by PI 3Ј-kinase inhibitors. Taken together, Ang1-induced sprouting process in vivo may be accomplished by enhanced cytoskeletal changes and secretion of proteinases mainly mediated through intracellular PI 3Ј-kinase activation.
